Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The current and future state of the ESRD program: a provider roundtable.

A R Nissenson1, J M Lazarus, S M Lindenfeld

  • 1UCLA School of Medicine, Los Angeles, CA, USA.

Seminars in Nephrology
|January 11, 2000
PubMed
Summary

The US dialysis industry has consolidated, with large companies now managing most patients. Physicians discussed industry consolidation, future challenges, and policy needs, emphasizing the balance between high-quality care and cost-effectiveness in end-stage renal disease (ESRD) programs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to "Disparities in provision of transplant information affect access to kidney transplantation" by Kucirka et al.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

Toward a continuous quality improvement paradigm for hemodialysis providers with preliminary suggestions for clinical practice monitoring and measurement.

Hemodialysis international. International Symposium on Home Hemodialysis·2009
Same author

Extremes of glycemic control (HbA1c) increase hospitalization risk in diabetic hemodialysis patients in the USA.

American journal of nephrology·2008
Same author

The new FDA label for erythropoietin treatment: how does it affect hemoglobin target?

Kidney international·2007

Area of Science:

  • Health Services Research
  • Health Economics
  • Nephrology

Background:

  • The 1990s witnessed significant consolidation in the US dialysis industry.
  • A few large, integrated companies now provide care for over two-thirds of dialysis patients.
  • This trend raises questions about the future vision for the End-Stage Renal Disease (ESRD) program.

Purpose of the Study:

  • To gather insights from senior physicians in major dialysis organizations on industry consolidation.
  • To explore perspectives on the advantages, disadvantages, and future challenges of industry consolidation.
  • To understand anticipated and desired policy changes impacting the ESRD program.

Main Methods:

  • A provider roundtable discussion was conducted.
  • Senior physicians from the four largest dialysis organizations participated.

Related Experiment Videos

  • Discussions focused on industry consolidation, organizational strategies, future issues, and policy recommendations.

    • Main Results:

    • Physicians shared diverse views on consolidation's pros and cons and organizational strategies.
    • Key industry issues for the next decade were identified.
    • Anticipated and desired federal government policy changes were discussed.
    • A central theme was maintaining program value through a balance of high-quality outcomes and cost-efficiency.

    Conclusions:

    • Industry consolidation presents complex challenges and opportunities for the ESRD program.
    • Balancing high-quality patient outcomes with cost-effectiveness is the primary challenge ahead.
    • Physician perspectives highlight the need for strategic planning and policy adaptation in the evolving dialysis landscape.